• FDA Advisory Committee Not Convinced of Linhaliq’s Benefits in Bronchiectasis Infections
  • Bronchiectasis May Trigger Autoimmune Inflammatory Disease, Study Suggests
  • Top 10 Bronchiectasis Stories of 2017
  • Artery Condition Increases Risk of Bronchiectasis Patients Having Heart Problem, Study Finds
  • Bronchiectasis Increases Risk of Stroke and Cognitive Dysfunction, Study Suggests
  • FDA Advisory Group Set to Review Linhaliq, Potential Non-CF Bronchiectasis Treatment, on Jan. 11
  • Antidepressants Increase Older People’s Risk of Developing Bronchiectasis, Study Reports
  • Pseudomonas aeruginosa Infection in NCFBE Patients Leads to Higher Healthcare Costs, Study Finds
  • Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US
  • FDA Panel Opposes Approving Cipro DPI to Treat Non-CF Bronchiectasis
  • Bronchiectasis More Prevalent in US Than Previously Thought, Study Finds
  • Pilot Study to Test Nitric Oxide Gas Treatment on Nontuberculous Mycobacteria Infections